- Home
- FCO vs BYSI Comparison
FCO vs BYSI Comparison
Compare FCO & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCO
- BYSI
- Stock Information
- Founded
- FCO 1991
- BYSI 2010
- Country
- FCO United Kingdom
- BYSI United States
- Employees
- FCO N/A
- BYSI N/A
- Industry
- FCO Investment Managers
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- FCO Finance
- BYSI Health Care
- Exchange
- FCO Nasdaq
- BYSI Nasdaq
- Market Cap
- FCO 80.3M
- BYSI 69.3M
- IPO Year
- FCO N/A
- BYSI 2017
- Fundamental
- Price
- FCO $5.98
- BYSI $1.72
- Analyst Decision
- FCO
- BYSI
- Analyst Count
- FCO 0
- BYSI 0
- Target Price
- FCO N/A
- BYSI N/A
- AVG Volume (30 Days)
- FCO 100.1K
- BYSI 21.8K
- Earning Date
- FCO 01-01-0001
- BYSI 01-01-0001
- Dividend Yield
- FCO 14.96%
- BYSI N/A
- EPS Growth
- FCO N/A
- BYSI N/A
- EPS
- FCO 0.43
- BYSI N/A
- Revenue
- FCO N/A
- BYSI $1,876,000.00
- Revenue This Year
- FCO N/A
- BYSI N/A
- Revenue Next Year
- FCO N/A
- BYSI N/A
- P/E Ratio
- FCO $12.30
- BYSI N/A
- Revenue Growth
- FCO N/A
- BYSI 21.03
- 52 Week Low
- FCO $4.73
- BYSI $0.82
- 52 Week High
- FCO $6.63
- BYSI $4.00
- Technical
- Relative Strength Index (RSI)
- FCO 54.52
- BYSI 52.47
- Support Level
- FCO $5.91
- BYSI $1.58
- Resistance Level
- FCO $5.98
- BYSI $1.75
- Average True Range (ATR)
- FCO 0.10
- BYSI 0.09
- MACD
- FCO 0.01
- BYSI 0.02
- Stochastic Oscillator
- FCO 71.05
- BYSI 74.07
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.